Abstract
The risk of acute intracranial complications after minor head injury (MHI) is low. Despite this, computed tomography (CT) is generally recommended with clinical observation as a secondary option. Both options have disadvantages. Clinical studies have shown the potential advantages of using the biomarker S100B. The specificity of S100B is low, but a high sensitivity for brain damage results in a clinically useful, high negative predictive value (NPV). Integration of S100B into existing management routines can reduce the need for CT scans or admission by over 30%.
Translated title of the contribution | Managing patients with minor head injury with a simple blood test - secondary publication |
---|---|
Original language | Danish |
Pages (from-to) | 978-981 |
Number of pages | 4 |
Journal | Ugeskrift for Laeger |
Volume | 171 |
Issue number | 12 |
Publication status | Published - Mar 2009 |
Externally published | Yes |